Diabetic ketoacidosis associated with atypical antipsychotic drug, clozapine treatment: Report of a case and review of literature

被引：2

作者：

Pillai, L. ^{[1
]}

Husainy, S. M. K. ^{[1
]}

Ramchandani, K. ^{[1
]}

机构：

[1] Lokmanya Hosp, Dept Critical Care Med, Pune 411033, Maharashtra, India

来源：

INDIAN JOURNAL OF CRITICAL CARE MEDICINE | 2006年 / 10卷 / 03期

关键词：

Atypical antipsychotics; clozapine; diabetic ketoacidosis lactic acidosis; respiridone;

D O I：

10.4103/0972-5229.27863

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Atypical antipsychotic drugs are associated with metabolic disturbances like weight gain, type 2 diabetes hyperglycaemia and dyslipedemia, which can result in serious health risk in patients. Diabetic ketoacidosis resulting in serious metabolic acidosis, occurring in a schizophrenic patient on treatment with clozapine is being reported to draw attention this association. Frequent monitoring of the blood sugar and lipids is advised before and during therapy with atypical antipsychotic drugs.

引用

页码：193 / 196

页数：4

共 14 条

[1] Atypical antipsychotic drug use and diabetes [J].

Ananth, J ;

Venkatesh, R ;

Burgoyne, K ;

Gunatilake, S .

PSYCHOTHERAPY AND PSYCHOSOMATICS, 2002, 71 (05) :244-254

[2] Atypical antipsychotics and glucose homeostasis [J].

Bergman, RN ;

Ader, M .

JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (04) :504-514

[3] Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications [J].

Hagg, S ;

Joelsson, L ;

Mjorndal, T ;

Spigset, O ;

Oja, G ;

Dahlqvist, R .

JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 (06) :294-299

[4]

Haupt DW, 2001, J CLIN PSYCHIAT, V62, P15

[5] Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study [J].

Henderson, DC ;

Cagliero, E ;

Gray, C ;

Nasrallah, RA ;

Hayden, DL ;

Schoenfeld, DA ;

Goff, DC .

AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (06) :975-981

[6]

Jin Hua, 2002, Ann Clin Psychiatry, V14, P59, DOI 10.1023/A:1015228112495

[7] Clozapine-associated diabetes [J].

Koller, E ;

Schneider, B ;

Bennett, K ;

Dubitsky, G .

AMERICAN JOURNAL OF MEDICINE, 2001, 111 (09) :716-723

[8] Lactic acidosis and fatal myocardial failure due to clozapine [J].

Koren, W ;

Kreis, Y ;

Duchowiczny, K ;

Prince, T ;

Sancovici, S ;

Sidi, Y ;

Gur, H .

ANNALS OF PHARMACOTHERAPY, 1997, 31 (02) :168-170

[9] A retrospective chart review of the clinical effects of atypical antipsychotic drugs on glycemic control in institutionalized patients with schizophrenia and comorbid diabetes mellitus [J].

Krosnick, A ;

Wilson, MG .

CLINICAL THERAPEUTICS, 2005, 27 (03) :320-326

[10] Patients on atypical antipsychotic drugs - Another high-risk group for type 2 diabetes [J].

Lean, MEJ ;

Pajonk, FG .

DIABETES CARE, 2003, 26 (05) :1597-1605

← 1 2 →